content: <HTML>
  <HEAD>
       <TITLE></TITLE>
  </HEAD>
  <BODY STYLE="font: 10pt Times New Roman, Times, Serif">
  
  <P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><B>As filed with the Securities and Exchange Commission on February
  27, 2019</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Registration No. 333-______</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top; text-align: left">
      <TD STYLE="width: 100%; border-top: Black 3pt double">&nbsp;</TD></TR>
  </TABLE>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>UNITED STATES</B></P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">SECURITIES
  AND EXCHANGE COMMISSION</P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">WASHINGTON,
  D.C. 20549</P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">FORM S-8</P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">REGISTRATION
  STATEMENT</P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">UNDER</P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">THE SECURITIES
  ACT OF 1933</P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ADMA BIOLOGICS, INC.</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in
  its charter)</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 40%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Delaware</B></FONT></TD>
      <TD STYLE="width: 2%; text-align: justify">&nbsp;</TD>
      <TD STYLE="width: 40%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>56-2590442</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(State or other jurisdiction of</FONT></TD>
      <TD STYLE="text-align: left">&nbsp;</TD>
      <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(I.R.S. Employer Identification No.)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">incorporation or organization)</FONT></TD>
      <TD STYLE="text-align: left">&nbsp;</TD>
      <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: center">&nbsp;</TD>
      <TD STYLE="text-align: left">&nbsp;</TD>
      <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>465 State Route 17</B></FONT></TD>
      <TD STYLE="text-align: left">&nbsp;</TD>
      <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR>
      <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Ramsey, New Jersey</B></FONT></TD>
      <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD>
      <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>07446</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(Address of Principal Executive Offices)</FONT></TD>
      <TD STYLE="text-align: left">&nbsp;</TD>
      <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(Zip Code)</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AMENDED AND RESTATED ADMA BIOLOGICS,
  INC. 2014 OMNIBUS INCENTIVE COMPENSATION PLAN</B>&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Full title of the plan)</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 40%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Adam S. Grossman&nbsp;</B></FONT></TD>
      <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
      <TD STYLE="width: 40%; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>President and Chief Executive Officer</B></FONT></TD>
      <TD STYLE="text-align: center">&nbsp;</TD>
      <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>David C. Schwartz, Esq.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>ADMA Biologics, Inc.</B></FONT></TD>
      <TD STYLE="text-align: center">&nbsp;</TD>
      <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>DLA Piper LLP (US)</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>465 State Route 17</B></FONT></TD>
      <TD STYLE="text-align: center">&nbsp;</TD>
      <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>51 John F. Kennedy Parkway, Suite 120</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>Ramsey, New Jersey 07446</B></FONT></TD>
      <TD STYLE="text-align: center">&nbsp;</TD>
      <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><B>Short Hills, New Jersey 07078</B></FONT></TD></TR>
  <TR>
      <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>(201) 478-5552</B></FONT></TD>
      <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
      <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>&nbsp;(973) 520-2550</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(Name, address, telephone number,</FONT></TD>
      <TD STYLE="text-align: center">&nbsp;</TD>
      <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(With copies to)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">including area code, of agent for service)</FONT></TD>
      <TD STYLE="text-align: center">&nbsp;</TD>
      <TD STYLE="text-align: center">&nbsp;</TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Indicate by check
  mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company,
  or an emerging growth company. See the definitions of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer,&rdquo; &ldquo;smaller
  reporting company,&rdquo; and &ldquo;emerging growth company&rdquo; in Rule 12b-2 of the Exchange Act. (Check one):</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 20%; padding-left: 0.1in; text-align: center; text-indent: -0.1in"><FONT STYLE="font-size: 10pt">Large accelerated filer&nbsp;<FONT STYLE="font-family: Wingdings">o</FONT></FONT></TD>
      <TD STYLE="width: 20%; text-align: center"><FONT STYLE="font-size: 10pt">Accelerated filer&nbsp;<FONT STYLE="font-family: Wingdings">&yacute;</FONT></FONT></TD>
      <TD STYLE="width: 20%">
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Non-accelerated filer&nbsp;<FONT STYLE="font-family: Wingdings">o</FONT></P>
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P></TD>
      <TD STYLE="width: 20%; text-align: center"><FONT STYLE="font-size: 10pt">Smaller reporting company&nbsp;<FONT STYLE="font-family: Wingdings">&yacute;</FONT></FONT></TD>
      <TD STYLE="width: 20%; text-align: center"><FONT STYLE="font-size: 10pt">Emerging growth company&nbsp;<FONT STYLE="font-family: Wingdings">o</FONT></FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">If an emerging growth
  company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any
  new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. &nbsp;<FONT STYLE="font-family: Wingdings">o</FONT></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">CALCULATION
  OF REGISTRATION FEE</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
      <TD STYLE="width: 20%; text-align: justify; border-bottom: Black 2.5pt double">&nbsp;</TD>
      <TD STYLE="width: 20%; text-align: justify; border-bottom: Black 2.5pt double">&nbsp;</TD>
      <TD STYLE="width: 20%; text-align: justify; border-bottom: Black 2.5pt double">&nbsp;</TD>
      <TD STYLE="width: 20%; text-align: justify; border-bottom: Black 2.5pt double">&nbsp;</TD>
      <TD STYLE="width: 20%; text-align: justify; border-bottom: Black 2.5pt double">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
      <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title of securities</B></FONT><BR>
  <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>to be registered</B></FONT></TD>
      <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amount to be</B></FONT><BR>
  <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>registered (1)</B></FONT></TD>
      <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposed</B></FONT><BR>
  <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>maximum</B></FONT><BR>
  <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>offering price</B></FONT><BR>
  <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>per share (2)</B></FONT></TD>
      <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposed</B></FONT><BR>
  <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>maximum</B></FONT><BR>
  <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>aggregate offering</B></FONT><BR>
  <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>price (2)</B></FONT></TD>
      <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amount of</B></FONT><BR>
  <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>registration fee</B></FONT></TD></TR>
  <TR>
      <TD STYLE="vertical-align: top; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-size: 10pt">Common Stock, $0.0001 par value per share</FONT></TD>
      <TD STYLE="vertical-align: bottom; border-bottom: Black 2.5pt double; text-align: center"><FONT STYLE="font-size: 10pt">1,854,122</FONT></TD>
      <TD STYLE="vertical-align: bottom; border-bottom: Black 2.5pt double; text-align: center"><FONT STYLE="font-size: 10pt">$3.96</FONT></TD>
      <TD STYLE="vertical-align: bottom; border-bottom: Black 2.5pt double; text-align: center"><FONT STYLE="font-size: 10pt">$7,342,323.12</FONT></TD>
      <TD STYLE="vertical-align: bottom; border-bottom: Black 2.5pt double; text-align: center"><FONT STYLE="font-size: 10pt">$890</FONT></TD></TR>
  </TABLE>
  
  <P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
  <TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(1)</TD><TD STYLE="text-align: justify">1,854,122 shares of common stock, $0.0001 par value per share (&ldquo;Common Stock&rdquo;), of
  ADMA Biologics, Inc. (the &ldquo;Registrant&rdquo;) were automatically added to the shares authorized for issuance under the Amended
  and Restated ADMA Biologics, Inc. 2014 Omnibus Incentive Compensation Plan (the &ldquo;2014 Plan&rdquo;), on January 1, 2019 pursuant
  to an &ldquo;evergreen&rdquo; provision contained in the 2014 Plan. Pursuant to such provision, on January 1 of each year through
  2022, the number of shares authorized for issuance under the 2014 Plan is automatically increased by a number equal to 4% of the
  outstanding shares of Common Stock as of the end of Registrant&rsquo;s immediately preceding fiscal year, or any lesser number
  of shares of Common Stock determined by the board of directors of the Registrant. In addition, pursuant to Rule 416(c) under the
  Securities Act of 1933, as amended, this Registration Statement on Form S-8 also covers an indeterminate number of shares of Common
  Stock which may be offered or issued to prevent dilution resulting from adjustments as a result of stock dividends, stock splits,
  reverse stock splits, recapitalizations, reclassifications, mergers, split-ups, reorganizations, consolidations and other capital
  adjustments.</TD></TR></TABLE>
  
  <P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(2)</TD><TD STYLE="text-align: justify">Estimated solely for purposes of calculating the registration fee pursuant to Rule 457(c) and (h).
  The proposed maximum offering price per share, proposed maximum aggregate offering price and the amount of the registration fee
  are based on the average of the high and low prices of Registrant&rsquo;s Common Stock as reported on the Nasdaq Capital Market
  on February 21, 2019. Pursuant to General Instruction E of Form S-8, the registration fee is calculated with respect to the additional
  securities registered on this Form S-8 only.</TD></TR></TABLE>
  
  <P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
  
  <P STYLE="margin-top: 0; margin-bottom: 0"></P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top; text-align: left">
      <TD STYLE="width: 100%; border-bottom: Black 3pt double">&nbsp;</TD></TR>
  </TABLE>
  
  <P STYLE="margin-top: 0; margin-bottom: 0"></P>
  
  <!-- Field: Page; Sequence: 1 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXPLANATORY NOTE</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Registration Statement on Form S-8
  (this &ldquo;Registration Statement&rdquo;) is being filed for the purpose of registering an additional 1,854,122 shares of common
  stock, $0.0001 par value per share (the &ldquo;Common Stock&rdquo;), of ADMA Biologics, Inc. (the &ldquo;Registrant&rdquo;) that
  were added to the shares authorized for issuance under the Amended and Restated ADMA Biologics, Inc. 2014 Omnibus Incentive Compensation
  Plan (the &ldquo;2014 Plan&rdquo;) for which registration statements on Form S-8 relating to the same employee benefit plan are
  effective.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Registrant previously filed the
  Registration Statements on Form S-8 (File Nos. 333-224492, 333-220058 and 333-204590) on April 27, 2018, August 18, 2017 and
  May 29, 2015, respectively, with the Securities and Exchange Commission (the &ldquo;Commission&rdquo;) to register an
  aggregate of 5,412,666 shares of Common Stock that were authorized for issuance under the 2014 Plan (collectively, the
  &ldquo;Prior Registration Statements&rdquo;). Upon the effectiveness of this Registration Statement, an aggregate of
  7,266,788 shares of Common Stock will be registered for issuance from time to time under the 2014 Plan. Pursuant to General
  Instruction E to Form S-8, the contents of the Prior Registration Statements are incorporated herein by reference except to
  the extent supplemented, amended or superseded by the information set forth herein. Only those items of Form S-8 containing
  new information not contained in the Prior Registration Statements are presented herein.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">INCORPORATION
  BY REFERENCE</P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In accordance with
  General Instruction E to Form S-8, the contents of the Prior Registration Statements, with respect to securities offered pursuant
  to the 2014 Plan, are hereby incorporated by reference.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following documents
  previously filed by the Registrant with the Commission are incorporated herein by reference and shall be deemed to be a part hereof:</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
  Registrant&rsquo;s Annual Report on Form 10-K for the year ended December 31, 2017, filed with the Commission on March 29, 2018;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
  Registrant&rsquo;s Quarterly Reports on Form 10-Q for the quarters ended March 31, 2018, June 30, 2018 and September 30, 2018,
  filed with the Commission on May 14, 2018, August 10, 2018 and November 9, 2018, respectively;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(3)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
  Registrant&rsquo;s Current Reports on Form 8-K filed with the Commission on February 15, 2018, February 16, 2018, April 24, 2018,
  May 14, 2018, May 16, 2018, June 8, 2018, June 12, 2018, June 18, 2018, June 22, 2018, June 25, 2018, July 3, 2018, July 24, 2018,
  July 26, 2018 (two reports), August 27, 2018, September 5, 2018 (two reports), October 1, 2018, October 3, 2018, October 11, 2018,
  October 17, 2018, December 19, 2018, December 20, 2018 (two reports), January 2, 2019, January 7, 2019, January 29, 2019, February
  12, 2019 and February 25, 2019 (provided that any portions of such reports that are deemed furnished and not filed pursuant to
  instructions to Form 8-K shall not be incorporated by reference into this Registration Statement); and</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(4)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
  description of Common Stock set forth in the Registrant&rsquo;s Registration Statement on Form 8-A12B filed with the Commission
  on November 5, 2014 pursuant to Section 12(b) of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;),
  including any amendment or report filed for the purpose of updating such description.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, all documents
  that the Registrant files pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act subsequent to the effective date
  of this Registration Statement (except for any portions of the Registrant&rsquo;s Current Reports on Form 8-K furnished pursuant
  to Item 2.02 or Item 7.01 thereof and any corresponding exhibits thereto not filed with the Commission), but prior to the filing
  of a post-effective amendment to this Registration Statement indicating that all securities offered hereby have been sold or which
  deregisters all securities then remaining unsold shall be deemed to be incorporated by reference in this Registration Statement
  and to be a part hereof from the date of filing such documents.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For purposes of this
  Registration Statement, any document or statement contained in a document incorporated or deemed to be incorporated by reference
  herein shall be deemed to be modified or superseded to the extent that a statement contained herein or in any other subsequently
  filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such document or statement
  in such document. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute
  a part of this Registration Statement.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>
  
  <!-- Field: Page; Sequence: 2 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">EXHIBITS</P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
      <TD STYLE="width: 11%; padding-left: 0.1in; text-align: left; text-indent: -0.1in"><FONT STYLE="font-size: 10pt"><B>EXHIBIT</B></FONT></TD>
      <TD STYLE="width: 2%; text-align: left">&nbsp;</TD>
      <TD STYLE="width: 87%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
      <TD STYLE="border-bottom: Black 1pt solid; padding-left: 0.1in; text-align: left; text-indent: -0.1in"><FONT STYLE="font-size: 10pt"><B>NUMBER</B></FONT></TD>
      <TD STYLE="text-align: left">&nbsp;</TD>
      <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 10pt"><B>DESCRIPTION</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-left: 0.1in; text-align: justify; text-indent: -0.1in">&nbsp;</TD>
      <TD STYLE="text-align: justify">&nbsp;</TD>
      <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-left: 0.1in; text-align: justify; text-indent: -0.1in"><FONT STYLE="font-size: 10pt">5.1</FONT></TD>
      <TD STYLE="text-align: justify">&nbsp;</TD>
      <TD>
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Opinion of DLA Piper LLP (US),
  counsel for the Registrant, regarding the legal validity of the shares of Common Stock being registered on this Registration Statement
  (filed herewith).</P></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-left: 0.1in; text-align: justify; text-indent: -0.1in">&nbsp;</TD>
      <TD STYLE="text-align: justify">&nbsp;</TD>
      <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-left: 0.1in; text-align: justify; text-indent: -0.1in"><FONT STYLE="font-size: 10pt">10.1</FONT></TD>
      <TD STYLE="text-align: justify">&nbsp;</TD>
      <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Amended and Restated ADMA Biologics, Inc. 2014 Omnibus Incentive Compensation Plan (incorporated herein by reference to Exhibit 10.1 to the Registrant&rsquo;s Registration Statement on Form S-8 filed on August 18, 2017</FONT><FONT STYLE="font-size: 10pt">).</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-left: 0.1in; text-align: justify; text-indent: -0.1in">&nbsp;</TD>
      <TD STYLE="text-align: justify">&nbsp;</TD>
      <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-left: 0.1in; text-align: justify; text-indent: -0.1in"><FONT STYLE="font-size: 10pt">23.1</FONT></TD>
      <TD STYLE="text-align: justify">&nbsp;</TD>
      <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Consent of DLA Piper LLP (US) (contained in Exhibit 5.1).</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-left: 0.1in; text-align: justify; text-indent: -0.1in">&nbsp;</TD>
      <TD STYLE="text-align: justify">&nbsp;</TD>
      <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-left: 0.1in; text-align: justify; text-indent: -0.1in"><FONT STYLE="font-size: 10pt">23.2</FONT></TD>
      <TD STYLE="text-align: justify">&nbsp;</TD>
      <TD>
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Consent of CohnReznick LLP, the
  Registrant&rsquo;s Independent Registered Public Accounting Firm (filed herewith).</P></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-left: 0.1in; text-align: justify; text-indent: -0.1in">&nbsp;</TD>
      <TD STYLE="text-align: justify">&nbsp;</TD>
      <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-left: 0.1in; text-align: justify; text-indent: -0.1in"><FONT STYLE="font-size: 10pt">24.1</FONT></TD>
      <TD STYLE="text-align: justify">&nbsp;</TD>
      <TD>
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Power of Attorney (included on
  signature page).</P></TD></TR>
  </TABLE>
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"></P>
  
  <!-- Field: Page; Sequence: 3 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">SIGNATURES</P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
  of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all
  of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned,
  thereunto duly authorized, in the City of Ramsey, State of New Jersey, on this 27th day of February, 2019.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: justify">&nbsp;</TD>
      <TD COLSPAN="2">
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>ADMA Biologics, Inc.</B></P>
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(Registrant)</P></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: justify">&nbsp;</TD>
      <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 51%; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="width: 3%; text-align: left"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
      <TD STYLE="width: 46%; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 10pt">/s/ Adam S. Grossman</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: left">&nbsp;</TD>
      <TD STYLE="text-align: left">&nbsp;</TD>
      <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Name: Adam S. Grossman</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Title: President and Chief Executive Officer</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>
  
  <!-- Field: Page; Sequence: 4 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">KNOW BY ALL MEN BY
  THESE PRESENTS, that each person whose signature appears below constitutes and appoints Adam S. Grossman and Brian Lenz, and each
  of them, the undersigned&rsquo;s true and lawful attorneys-in-fact and agents, with full power of substitution and revocation,
  for and in the undersigned&rsquo;s name, place and stead, in any and all capacities, to sign any and all amendments (including
  post-effective amendments) to this Registration Statement on Form S-8 (this &ldquo;Registration Statement&rdquo;) and any registration
  statement filed pursuant to Rule 462(b) under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), and to
  file the same, with all exhibits thereto, and other documents in connection therewith, with the Commission, granting unto said
  attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite
  and necessary to be done, as fully to all intents and purposes as the undersigned might or could do in person, hereby ratify and
  confirming all that said attorneys-in-fact and agents or any of them, or their or his substitutes, may lawfully do or cause to
  be done by virtue thereof.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
  of the Securities Act, this Registration Statement has been signed below by the following persons on behalf of the Registrant and
  in the capacities indicated on the date listed below.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
      <TD STYLE="vertical-align: bottom; width: 30%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Signature</B></FONT></TD>
      <TD STYLE="vertical-align: bottom; width: 2%; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top; width: 40%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Capacity</B></FONT></TD>
      <TD STYLE="width: 2%">&nbsp;</TD>
      <TD STYLE="vertical-align: top; width: 25%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date</B></FONT></TD></TR>
  <TR>
      <TD STYLE="vertical-align: bottom">&nbsp;</TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
  <TR>
      <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Adam S. Grossman</FONT></TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President and Chief Executive Officer</FONT></TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February 27, 2019</FONT></TD></TR>
  <TR>
      <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;Adam S. Grossman</FONT></TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Executive Officer)</FONT></TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
  <TR>
      <TD STYLE="vertical-align: bottom">&nbsp;</TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
  <TR>
      <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Brian Lenz</FONT></TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive Vice President and Chief Financial Officer</FONT></TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February 27, 2019</FONT></TD></TR>
  <TR>
      <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian Lenz</FONT></TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Financial Officer and Principal Accounting Officer)</FONT></TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
  <TR>
      <TD STYLE="vertical-align: bottom">&nbsp;</TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
  <TR>
      <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Steven A. Elms</FONT></TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman of the Board of Directors&nbsp; </FONT></TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February 27, 2019</FONT></TD></TR>
  <TR>
      <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;Steven A. Elms</FONT></TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
  <TR>
      <TD STYLE="vertical-align: bottom">&nbsp;</TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
  <TR>
      <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Dr. Jerrold B. Grossman</FONT></TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vice Chairman of the Board of Directors</FONT></TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February 27, 2019</FONT></TD></TR>
  <TR>
      <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;Dr. Jerrold B. Grossman</FONT></TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
  <TR>
      <TD STYLE="vertical-align: bottom">&nbsp;</TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
  <TR>
      <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Bryant E. Fong</FONT></TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February 27, 2019</FONT></TD></TR>
  <TR>
      <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;Bryant E. Fong</FONT></TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
  <TR>
      <TD STYLE="vertical-align: bottom">&nbsp;</TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
  <TR>
      <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Dov A. Goldstein, M.D.</FONT></TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February 27, 2019</FONT></TD></TR>
  <TR>
      <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dov A. Goldstein, M.D.</FONT></TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top"></TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top">
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P></TD></TR>
  <TR>
      <TD STYLE="vertical-align: bottom">&nbsp;</TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
  <TR>
      <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Lawrence P. Guiheen</FONT></TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: center">February 27, 2019</TD></TR>
  <TR>
      <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lawrence P. Guiheen</FONT></TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
  <TR>
      <TD STYLE="vertical-align: bottom">&nbsp;</TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
  <TR>
      <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Eric I. Richman</FONT></TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February 27, 2019&nbsp;</FONT></TD></TR>
  <TR>
      <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eric I. Richman</FONT></TD>
      <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
      <TD STYLE="vertical-align: top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  </TABLE>
  
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"></P>
  
  <!-- Field: Page; Sequence: 5 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">EXHIBIT
  INDEX</P>
  
  <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
      <TD STYLE="width: 11%; padding-left: 0.1in; text-align: left; text-indent: -0.1in"><FONT STYLE="font-size: 10pt"><B>EXHIBIT</B></FONT></TD>
      <TD STYLE="width: 2%; text-align: left">&nbsp;</TD>
      <TD STYLE="width: 87%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
      <TD STYLE="border-bottom: Black 1pt solid; padding-left: 0.1in; text-align: left; text-indent: -0.1in"><FONT STYLE="font-size: 10pt"><B>NUMBER</B></FONT></TD>
      <TD STYLE="text-align: left">&nbsp;</TD>
      <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 10pt"><B>DESCRIPTION</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-left: 0.1in; text-align: justify; text-indent: -0.1in">&nbsp;</TD>
      <TD STYLE="text-align: justify">&nbsp;</TD>
      <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD>
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1in; text-align: justify; text-indent: -0.1in">5.1</P>
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1in; text-align: justify; text-indent: -0.1in">&nbsp;</P></TD>
      <TD STYLE="text-align: justify">&nbsp;</TD>
      <TD>
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A HREF="e618261_ex5-1.htm" STYLE="-sec-extract: exhibit">Opinion of DLA Piper LLP (US), counsel for the Registrant, regarding the legal validity of the shares of Common Stock being registered on this Registration Statement (filed herewith).</A></P></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD>&nbsp;</TD>
      <TD STYLE="text-align: justify">&nbsp;</TD>
      <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD>10.1</TD>
      <TD STYLE="text-align: justify">&nbsp;</TD>
      <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1368514/000119380517001506/e616485_ex10-1.htm" STYLE="-sec-extract: exhibit">Amended and Restated ADMA Biologics, Inc. 2014 Omnibus Incentive Compensation Plan (incorporated herein by reference to Exhibit 10.1 to the Registrant?s Registration Statement on Form S-8 filed on August 18, 2017).</A></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-left: 0.1in; text-align: justify; text-indent: -0.1in">&nbsp;</TD>
      <TD STYLE="text-align: justify">&nbsp;</TD>
      <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-left: 0.1in; text-align: justify; text-indent: -0.1in"><FONT STYLE="font-size: 10pt">23.1</FONT></TD>
      <TD STYLE="text-align: justify">&nbsp;</TD>
      <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><A HREF="e618261_ex5-1.htm" STYLE="-sec-extract: exhibit">Consent of DLA Piper LLP (US) (contained in Exhibit 5.1).</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-left: 0.1in; text-align: justify; text-indent: -0.1in">&nbsp;</TD>
      <TD STYLE="text-align: justify">&nbsp;</TD>
      <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-left: 0.1in; text-align: justify; text-indent: -0.1in"><FONT STYLE="font-size: 10pt">23.2</FONT></TD>
      <TD STYLE="text-align: justify">&nbsp;</TD>
      <TD>
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A HREF="e618261_ex23-2.htm" STYLE="-sec-extract: exhibit">Consent of CohnReznick LLP, the Registrant&rsquo;s Independent Registered Public Accounting Firm (filed herewith).</A></P></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-left: 0.1in; text-align: justify; text-indent: -0.1in">&nbsp;</TD>
      <TD STYLE="text-align: justify">&nbsp;</TD>
      <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-left: 0.1in; text-align: justify; text-indent: -0.1in"><FONT STYLE="font-size: 10pt">24.1</FONT></TD>
      <TD STYLE="text-align: justify">&nbsp;</TD>
      <TD>
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Power of Attorney (included on
  signature page).</P></TD></TR>
  </TABLE>
  
  
  <P STYLE="margin: 0">&nbsp;</P>
  
  <P STYLE="margin: 0">&nbsp;</P>
  
  <P STYLE="margin: 0">&nbsp;</P>
  
  </BODY>
  </HTML>
metadata_documents: [{"type": "S-8", "sequence": "1", "filename": "e618261_s8-adma.htm", "secsgml_size_bytes": 52197}]
metadata_filer: {"company-data": {"conformed-name": "ADMA BIOLOGICS, INC.", "cik": "0001368514", "assigned-sic": "2836", "irs-number": "562590442", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-229921", "film-number": "19638710"}, "business-address": {"street1": "C/O ADMA BIOLOGICS, INC.", "street2": "465 STATE ROUTE 17", "city": "RAMSEY", "state": "NJ", "zip": "07446", "phone": "(201) 478-5552"}, "mail-address": {"street1": "C/O ADMA BIOLOGICS, INC.", "street2": "465 STATE ROUTE 17", "city": "RAMSEY", "state": "NJ", "zip": "07446"}, "former-company": {"former-conformed-name": "R&R ACQUISITION VI, INC", "date-changed": "20060707"}}
text: As filed with the Securities and Exchange Commission on February
  27, 2019
  Registration No. 333-______
  UNITED STATES
  SECURITIES
  AND EXCHANGE COMMISSION
  WASHINGTON,
  D.C. 20549
  FORM S-8
  REGISTRATION
  STATEMENT
  UNDER
  THE SECURITIES
  ACT OF 1933
  ADMA BIOLOGICS, INC.
  (Exact name of registrant as specified in
  its charter)
  Delaware
  56-2590442
  (State or other jurisdiction of
  (I.R.S. Employer Identification No.)
  incorporation or organization)
  465 State Route 17
  Ramsey, New Jersey
  07446
  (Address of Principal Executive Offices)
  (Zip Code)
  AMENDED AND RESTATED ADMA BIOLOGICS,
  INC. 2014 OMNIBUS INCENTIVE COMPENSATION PLAN
  (Full title of the plan)
  Adam S. Grossman
  President and Chief Executive Officer
  David C. Schwartz, Esq.
  ADMA Biologics, Inc.
  DLA Piper LLP (US)
  465 State Route 17
  51 John F. Kennedy Parkway, Suite 120
  Ramsey, New Jersey 07446
  Short Hills, New Jersey 07078
  (201) 478-5552
  (973) 520-2550
  (Name, address, telephone number,
  (With copies to)
  including area code, of agent for service)
  Indicate by check
  mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company,
  or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller
  reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one):
  Large accelerated filer
  o
  Accelerated filer
  ý
  Non-accelerated filer
  o
  Smaller reporting company
  ý
  Emerging growth company
  o
  If an emerging growth
  company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any
  new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.
  o
  CALCULATION
  OF REGISTRATION FEE
  Title of securities
  to be registered
  Amount to be
  registered (1)
  Proposed
  maximum
  offering price
  per share (2)
  Proposed
  maximum
  aggregate offering
  price (2)
  Amount of
  registration fee
  Common Stock, $0.0001 par value per share
  1,854,122
  $3.96
  $7,342,323.12
  $890
  (1)
  1,854,122 shares of common stock, $0.0001 par value per share ("Common Stock"), of
  ADMA Biologics, Inc. (the "Registrant") were automatically added to the shares authorized for issuance under the Amended
  and Restated ADMA Biologics, Inc. 2014 Omnibus Incentive Compensation Plan (the "2014 Plan"), on January 1, 2019 pursuant
  to an "evergreen" provision contained in the 2014 Plan. Pursuant to such provision, on January 1 of each year through
  2022, the number of shares authorized for issuance under the 2014 Plan is automatically increased by a number equal to 4% of the
  outstanding shares of Common Stock as of the end of Registrant's immediately preceding fiscal year, or any lesser number
  of shares of Common Stock determined by the board of directors of the Registrant. In addition, pursuant to Rule 416(c) under the
  Securities Act of 1933, as amended, this Registration Statement on Form S-8 also covers an indeterminate number of shares of Common
  Stock which may be offered or issued to prevent dilution resulting from adjustments as a result of stock dividends, stock splits,
  reverse stock splits, recapitalizations, reclassifications, mergers, split-ups, reorganizations, consolidations and other capital
  adjustments.
  (2)
  Estimated solely for purposes of calculating the registration fee pursuant to Rule 457(c) and (h).
  The proposed maximum offering price per share, proposed maximum aggregate offering price and the amount of the registration fee
  are based on the average of the high and low prices of Registrant's Common Stock as reported on the Nasdaq Capital Market
  on February 21, 2019. Pursuant to General Instruction E of Form S-8, the registration fee is calculated with respect to the additional
  securities registered on this Form S-8 only.
  EXPLANATORY NOTE
  This Registration Statement on Form S-8
  (this "Registration Statement") is being filed for the purpose of registering an additional 1,854,122 shares of common
  stock, $0.0001 par value per share (the "Common Stock"), of ADMA Biologics, Inc. (the "Registrant") that
  were added to the shares authorized for issuance under the Amended and Restated ADMA Biologics, Inc. 2014 Omnibus Incentive Compensation
  Plan (the "2014 Plan") for which registration statements on Form S-8 relating to the same employee benefit plan are
  effective.
  The Registrant previously filed the
  Registration Statements on Form S-8 (File Nos. 333-224492, 333-220058 and 333-204590) on April 27, 2018, August 18, 2017 and
  May 29, 2015, respectively, with the Securities and Exchange Commission (the "Commission") to register an
  aggregate of 5,412,666 shares of Common Stock that were authorized for issuance under the 2014 Plan (collectively, the
  "Prior Registration Statements"). Upon the effectiveness of this Registration Statement, an aggregate of
  7,266,788 shares of Common Stock will be registered for issuance from time to time under the 2014 Plan. Pursuant to General
  Instruction E to Form S-8, the contents of the Prior Registration Statements are incorporated herein by reference except to
  the extent supplemented, amended or superseded by the information set forth herein. Only those items of Form S-8 containing
  new information not contained in the Prior Registration Statements are presented herein.
  INCORPORATION
  BY REFERENCE
  In accordance with
  General Instruction E to Form S-8, the contents of the Prior Registration Statements, with respect to securities offered pursuant
  to the 2014 Plan, are hereby incorporated by reference.
  The following documents
  previously filed by the Registrant with the Commission are incorporated herein by reference and shall be deemed to be a part hereof:
  (1)       The
  Registrant's Annual Report on Form 10-K for the year ended December 31, 2017, filed with the Commission on March 29, 2018;
  (2)       The
  Registrant's Quarterly Reports on Form 10-Q for the quarters ended March 31, 2018, June 30, 2018 and September 30, 2018,
  filed with the Commission on May 14, 2018, August 10, 2018 and November 9, 2018, respectively;
  (3)       The
  Registrant's Current Reports on Form 8-K filed with the Commission on February 15, 2018, February 16, 2018, April 24, 2018,
  May 14, 2018, May 16, 2018, June 8, 2018, June 12, 2018, June 18, 2018, June 22, 2018, June 25, 2018, July 3, 2018, July 24, 2018,
  July 26, 2018 (two reports), August 27, 2018, September 5, 2018 (two reports), October 1, 2018, October 3, 2018, October 11, 2018,
  October 17, 2018, December 19, 2018, December 20, 2018 (two reports), January 2, 2019, January 7, 2019, January 29, 2019, February
  12, 2019 and February 25, 2019 (provided that any portions of such reports that are deemed furnished and not filed pursuant to
  instructions to Form 8-K shall not be incorporated by reference into this Registration Statement); and
  (4)       The
  description of Common Stock set forth in the Registrant's Registration Statement on Form 8-A12B filed with the Commission
  on November 5, 2014 pursuant to Section 12(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"),
  including any amendment or report filed for the purpose of updating such description.
  In addition, all documents
  that the Registrant files pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act subsequent to the effective date
  of this Registration Statement (except for any portions of the Registrant's Current Reports on Form 8-K furnished pursuant
  to Item 2.02 or Item 7.01 thereof and any corresponding exhibits thereto not filed with the Commission), but prior to the filing
  of a post-effective amendment to this Registration Statement indicating that all securities offered hereby have been sold or which
  deregisters all securities then remaining unsold shall be deemed to be incorporated by reference in this Registration Statement
  and to be a part hereof from the date of filing such documents.
  For purposes of this
  Registration Statement, any document or statement contained in a document incorporated or deemed to be incorporated by reference
  herein shall be deemed to be modified or superseded to the extent that a statement contained herein or in any other subsequently
  filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such document or statement
  in such document. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute
  a part of this Registration Statement.
  EXHIBITS
  EXHIBIT
  NUMBER
  DESCRIPTION
  5.1
  Opinion of DLA Piper LLP (US),
  counsel for the Registrant, regarding the legal validity of the shares of Common Stock being registered on this Registration Statement
  (filed herewith).
  10.1
  Amended and Restated ADMA Biologics, Inc. 2014 Omnibus Incentive Compensation Plan (incorporated herein by reference to Exhibit 10.1 to the Registrant's Registration Statement on Form S-8 filed on August 18, 2017
  ).
  23.1
  Consent of DLA Piper LLP (US) (contained in Exhibit 5.1).
  23.2
  Consent of CohnReznick LLP, the
  Registrant's Independent Registered Public Accounting Firm (filed herewith).
  24.1
  Power of Attorney (included on
  signature page).
  SIGNATURES
  Pursuant to the requirements
  of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all
  of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned,
  thereunto duly authorized, in the City of Ramsey, State of New Jersey, on this 27th day of February, 2019.
  ADMA Biologics, Inc.
  (Registrant)
  By:
  /s/ Adam S. Grossman
  Name: Adam S. Grossman
  Title: President and Chief Executive Officer
  KNOW BY ALL MEN BY
  THESE PRESENTS, that each person whose signature appears below constitutes and appoints Adam S. Grossman and Brian Lenz, and each
  of them, the undersigned's true and lawful attorneys-in-fact and agents, with full power of substitution and revocation,
  for and in the undersigned's name, place and stead, in any and all capacities, to sign any and all amendments (including
  post-effective amendments) to this Registration Statement on Form S-8 (this "Registration Statement") and any registration
  statement filed pursuant to Rule 462(b) under the Securities Act of 1933, as amended (the "Securities Act"), and to
  file the same, with all exhibits thereto, and other documents in connection therewith, with the Commission, granting unto said
  attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite
  and necessary to be done, as fully to all intents and purposes as the undersigned might or could do in person, hereby ratify and
  confirming all that said attorneys-in-fact and agents or any of them, or their or his substitutes, may lawfully do or cause to
  be done by virtue thereof.
  Pursuant to the requirements
  of the Securities Act, this Registration Statement has been signed below by the following persons on behalf of the Registrant and
  in the capacities indicated on the date listed below.
  Signature
  Capacity
  Date
  /s/ Adam S. Grossman
  President and Chief Executive Officer
  February 27, 2019
  Adam S. Grossman
  (Principal Executive Officer)
  /s/ Brian Lenz
  Executive Vice President and Chief Financial Officer
  February 27, 2019
  Brian Lenz
  (Principal Financial Officer and Principal Accounting Officer)
  /s/ Steven A. Elms
  Chairman of the Board of Directors
  February 27, 2019
  Steven A. Elms
  /s/ Dr. Jerrold B. Grossman
  Vice Chairman of the Board of Directors
  February 27, 2019
  Dr. Jerrold B. Grossman
  /s/ Bryant E. Fong
  Director
  February 27, 2019
  Bryant E. Fong
  /s/ Dov A. Goldstein, M.D.
  Director
  February 27, 2019
  Dov A. Goldstein, M.D.
  /s/ Lawrence P. Guiheen
  Director
  February 27, 2019
  Lawrence P. Guiheen
  /s/ Eric I. Richman
  Director
  February 27, 2019
  Eric I. Richman
  EXHIBIT
  INDEX
  EXHIBIT
  NUMBER
  DESCRIPTION
  5.1
  Opinion of DLA Piper LLP (US), counsel for the Registrant, regarding the legal validity of the shares of Common Stock being registered on this Registration Statement (filed herewith).
  10.1
  Amended and Restated ADMA Biologics, Inc. 2014 Omnibus Incentive Compensation Plan (incorporated herein by reference to Exhibit 10.1 to the Registrant?s Registration Statement on Form S-8 filed on August 18, 2017).
  23.1
  Consent of DLA Piper LLP (US) (contained in Exhibit 5.1).
  23.2
  Consent of CohnReznick LLP, the Registrant's Independent Registered Public Accounting Firm (filed herewith).
  24.1
  Power of Attorney (included on
  signature page).